Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
4.9M
-
Shares change
-
+4.9M
-
Total reported value, excl. options
-
$26.2M
-
Value change
-
+$26.2M
-
Number of buys
-
9
-
Price
-
$5.35
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q3 2015
9 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q3 2015.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.9M shares
of 13.8M outstanding shares and own 35.39% of the company stock.
Largest 9 shareholders include Battery Partners IX, LLC (1.95M shares), NEA Management Company, LLC (1.56M shares), PAR CAPITAL MANAGEMENT INC (833K shares), PERCEPTIVE ADVISORS LLC (373K shares), SABBY MANAGEMENT, LLC (169K shares), MORGAN STANLEY (2.69K shares), BANK OF AMERICA CORP /DE/ (2.09K shares), Alexandria Capital, LLC (1.19K shares), and UBS Group AG (483 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.